Overview of MnDPDP as a pancreas-specific contrast agent for MR imaging

Acta Radiologica

Volumn 38, Issue 4 PART 2, 1997, Pages 660-664

  Ahlström, Häkan ^a   Gehl, H B ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Contrast media; MnDPDP; MR imaging; Pancreas

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EDETIC ACID; MANGANESE; N,N' BIS(PYRIDOXAL 5 PHOSPHATE)ETHYLENEDIAMINE N,N' DIACETIC ACID; N,N'-BIS(PYRIDOXAL-5-PHOSPHATE)ETHYLENEDIAMINE-N,N'-DIACETIC ACID; PYRIDOXAL 5 PHOSPHATE;

ACUTE DISEASE; HISTOLOGY; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREAS TUMOR; PANCREATITIS; REFERENCE VALUE; REVIEW;

ACUTE DISEASE; CONTRAST MEDIA; EDETIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MANGANESE; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS; PYRIDOXAL PHOSPHATE; REFERENCE VALUES;

EID: 0031182074     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841859709172398     Document Type: Article

References (18)

1. BABA Y., LERCH M. M., STARK D. D. et al.: Time after excision and temperature after ex vivo tissue relaxation time measurements. J. Magn. Reson. Imaging 4 (1994), 647.
2. BABA Y., LERCH M. M., TANIMOTO A. et al.: Enhancement of pancreas and diagnosis of pancreatitis using manganese dipyridoxyl diphosphate. Invest. Radiol. 29 (1994), 300.
3. BALTHAZAR E. J., ROBINSON D. L., MEGIBOW A. J. M. & RANSON J. H. C.: Acute pancreatitis. Value of CT in establishing prognosis. Radiology 174 (1990), 331.
4. COLEY B. D., MATTREY R. F., BAKER K. G., PETERSON T. & BURGAN A. R.: MR imaging assessment of experimental hepatic dysfunction with Mn-DPDP. J. Magn. Reson. Imaging 5 (1995), 11.
5. FOITZIK T., BASSI D. G., SCHMIDT J. et al.: Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in rat. Gastroenterology 106 (1994), 207.
6. GEHL H. B., MARKERT U., STRUCK J., BRUCH H. P. & WEISS H. D.: MR-Tomographie der akuten Pankreatitis. Erste Ergebnisse. Bildgebung 61 (1994), 169.
7. GEHL H. B., URHAHN R., BOHNDORF K. et al.: Mn-DPDP in MR imaging of pancreatic ductal adenocarcinomas. Initial clinical experience. Radiology 186 (1993), 795.
8. GEHL H. B., VORWERK D., KLOSE K. C. & GUNTHER R. W.: Pancreatic enhancement after low-dose infusion of Mn-DPDP. Radiology 180 (1991), 337.
9. JOHNSON C. D., STEPHENS D. H. & SARR M. G.: CT of acute pancreatitis. Correlation between lack of contrast enhancement and pancreatic necrosis. AJR 156 (1991), 93.
10. KELEKIS N. L., SEMELKA R. C., MOLINA P. L. & DOERR M. E.: ACTH-secreting islet cell tumor. Appearances on dynamic gadolinium-enhanced MRI. Magn. Reson. Imaging 13 (1995), 641.
11. KETTRITZ U., WARSHAUER D. M., BROWN E. D., SCHLUND F. J., EISENBERG L. B. & SEMELKA R. C.: Enhancement of the normal pancreas. Comparison of manganese-DPDP and gadolinium chelate. Eur. J. Radiol. 6 (1996), 14.
12. SEMELKA R. C., CUMMING M. J., SHOENUT J. P. et al.: Islet cell tumors. Comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology 186 (1993), 799.
13. SMEDBY O̊., RIESENFELD V., KARLSSON B.-M. et al.: Comparison of angiography, ultrasonography and magnetic resonance angiography in the evaluation of the portal venous system in pancreatic carcinoma. Accepted for publication in Eur. Radiol. (1997).
14. SOTO J. A., BARISH M. A., YUCEL E. K. et al.: Pancreatic duct MR cholangiopancreatography with a three-dimensional fast spin-echo technique. Radiology 196 (1995), 459.
15. TANIMOTO A., KREFT B., BABA Y. et al.: Evaluation of hepatocyte-specific paramagnetic contrast media for MR imaging of hepatitis. J. Magn. Reson. Imaging 3 (1993), 786.
16. TERHAVARTIALA P., KIVISAARI R. & VIRTANEN I.: Contrast media induced renal morphologic changes in rats with acute oedematous pancreatitis. Invest. Radiol. 27 (1992), 520.
17. WANG C., GORDON P. B., HUSTVEDT S. O. et al.: MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol. 38 (1997), 665.
18. YOUNG S. W., SIMPSON B. B., RATNER V., MATKIN C. & CARTER E. A.: MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese/pyridoxal 5-phosphate chelate. Magn. Reson. Med. 10 (1989), 1.